SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Annual Wellness Visit, Subsequent — Mary Seacole — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Mary Seacole |
|---|
| Date of birth | 1805-11-23 |
|---|
| Identifiers | MRN HR-NI027-SYN-TD; SSN (made up) 000-27-4483 |
|---|
| Document date | 1877-07-13 |
|---|
| Author | Adwoa Fairweather-Kent, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Subsequent annual wellness visit; no new complaints. [S]
History of Present Illness
Mary Seacole returns for her subsequent annual wellness visit, four weeks after her three-month review, when losartan 25 mg was added to amlodipine. She completed the health risk assessment beforehand. Her home readings average 130/78. She has had no dizziness on standing since chlorthalidone was stopped, no falls and no headaches. She goes to the tai chi class twice a week and to a lunch club on Fridays, walks most days with her cane, and says she speaks to more people than she has for a year. Her knees are better. She has kept liquorice paused, takes ginger tea and uses her own liniment on the right knee and the diclofenac gel on the left. She asked to talk about what she would want if she had a stroke. [S]
| Element | Detail |
|---|
| Visit | Subsequent annual wellness visit |
| Safety events | Near-fall with low sodium in May; no falls; no emergency visits or hospital stays |
| Medicines | Amlodipine, losartan, atorvastatin and diclofenac gel; her own ginger tea and liniment |
| Active conditions | Hypertension, knee osteoarthritis, fall risk and obesity |
| Functional status | Independent in all activities; help with heavy shopping |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|
| Self-rated health | Good |
| Psychosocial | Lives alone; less lonely since joining the tai chi class and lunch club; 3-item UCLA loneliness score 5 of 9, down from 7 |
| Behavioral | Never smoked; a small glass of wine on occasions; walks most days; less salted fish |
| Activities of daily living | Independent in bathing, dressing, eating, toileting and transfers |
| Instrumental activities of daily living | Manages her medicines and money; a neighbour helps with heavy shopping; does not drive |
| Home safety | Stair rail fitted after the occupational therapy visit; bath board; smoke alarm working; rugs removed |
| Hearing and vision | Hears well; reading glasses; eye examination two years ago |
| Bladder | Occasional urgency, no leakage |
| Memory | No concerns |
| Cost | Medicines now generic, in 90-day supplies; transport help arranged |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Negative | Weight down 1.2 kg since starting; no fatigue |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | Cold resolved; hearing normal |
| Cardiovascular | Negative | No chest pain, palpitations or dizziness on standing; mild ankle swelling in the evening |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No change in bowel habit or blood |
| Genitourinary | Negative | Occasional urgency; no leakage |
| Musculoskeletal | Positive | Knee pain on stairs, milder |
| Integumentary | Negative | No rash where she uses the gel or liniment |
| Neurological | Negative | No headaches, weakness, numbness or speech change |
| Psychiatric | Negative | Mood better; PHQ-2 score 1 |
| Hematologic | Negative | No bruising or bleeding |
12 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day | 4 g to each knee up to four times a day | Topical route | 1877-03-09 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-03-16 | active | S |
| Chlorthalidone 12.5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1877-03-16 to 1877-05-11 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-04-13 | active | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-06-15 | active | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1877-07-13 | Body height | 157 | cm | S |
| 1877-07-13 | Body weight | 76.8 | kg | S |
| 1877-07-13 | Body mass index (BMI) [Ratio] | 31.2 | kg/m2 | S |
| 1877-07-13 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1877-07-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1877-07-13 | Heart rate | 72 | /min | S |
| 1877-07-13 | Respiratory rate | 16 | /min | S |
| 1877-07-13 | Body temperature | 36.6 | Cel | S |
| 1877-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1877-07-13 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1877-07-13 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1877-07-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1877-07-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1872)/1.73 sq M | 62 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1877-07-13 | Glucose [Mass/volume] in Serum or Plasma | 93 | mg/dL | 70-99 mg/dL | Normal | S |
| 1877-07-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | | | S |
| 1877-07-13 | Total score [Mini-Cog] | 5 | {score} | | | S |
| 1877-07-13 | Total score [AUDIT-C] | 1 | {score} | | | S |
Physical Exam
Vital signs recorded on 1877-07-13; see the Vital Signs section. [S]
| System | Finding |
|---|
| Constitutional | Well and cheerful; blood pressure 132/78, pulse 72; no orthostatic drop; BMI 31.2 |
| Eyes | Near vision 20/30 with reading glasses |
| Ears | Whispered-voice test passed on both sides |
| Cardiovascular | Regular rhythm; no murmur; trace ankle edema |
| Respiratory | Clear |
| Breast | Not examined; screening mammography ordered |
| Musculoskeletal | Crepitus in both knees, no effusion; Timed Up and Go 12 seconds with the cane |
| Neurological | Oriented; Mini-Cog 5 of 5 |
| Skin | No irritation over either knee |
| Psychiatric | Engaged, warm and humorous |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmed | resolved | provisional |
R03.0 | S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health. |
| Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney disease | active | confirmed |
I10 | S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension. |
| Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imaging | active | confirmed |
M17.0 | S — Synthetic modern problem; not a claim about her real health. |
| Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 seconds | active | confirmed |
Z91.81 | S — Synthetic fall-risk problem. |
| Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her knees | active | confirmed |
E66.811 | S — Synthetic modern problem; her self-description as stout is documented, her weight is not. |
| Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stopped | resolved | confirmed |
E87.1 | S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis. |
Assessment and Plan
- Subsequent annual wellness visit completed. Health risk assessment reviewed, personalized prevention plan updated and a written copy given. Depression, alcohol and cognitive screens are negative; loneliness is improving; fall risk is lower but still present. [S]
- Next annual wellness visit in one year.
- Hypertension (I10). 132/78 in the clinic, 130/78 at home, close to target four weeks after losartan; potassium 4.4 mmol/L and creatinine 0.98 mg/dL (eGFR 62): losartan is safe to continue. [S]
- Continue amlodipine 5 mg and losartan 25 mg.
- Six-month review in two months.
- Fall risk (Z91.81). No falls; Timed Up and Go 12 seconds, down from 15; stair rail fitted. [S]
- Continue tai chi twice a week and walking.
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|
| Pneumococcal vaccine | Completed today | PCV20 today; no prior pneumococcal vaccine |
| Recombinant zoster vaccine | Completed today | Dose 1 today; dose 2 in two to six months |
| RSV vaccine | Not indicated | Recommended at 75 and older, or at 50 to 74 with a condition that raises risk; she has none of those conditions |
| Tetanus booster | Due | No record within ten years; Tdap at the six-month review |
| Influenza vaccine | Due | High-dose vaccine at the six-month review in the autumn |
| COVID-19 vaccine | Due | This season's vaccine in the autumn |
| Bone density (DXA) | Ordered | Never scanned; women 65 and older; her fall risk adds to the reason |
| Breast cancer screening | Ordered | Mammography every two years to age 74; none for three years; booked |
| Colorectal cancer screening | Ordered | Ages 45 to 75; she chose a home stool immunochemical test over colonoscopy; kit given |
| Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; never tested; blood drawn today |
| Cervical cancer screening | Not indicated | Not recommended after 65 with adequate prior screening, which she reports |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoked; aneurysm screening applies to men who have smoked |
| Depression screening | Completed today | PHQ-2 score 1; PHQ-9 6 at the geriatric assessment |
| Alcohol misuse screening | Completed today | AUDIT-C score 1 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls prevention | Completed today | Timed Up and Go 12 seconds; tai chi and stair rail |
| Blood pressure, cholesterol and diabetes screening | Up to date | Blood pressure at every visit; on atorvastatin, LDL 82 mg/dL at the three-month review; hemoglobin A1c 5.6% at intake |
Immunizations given today: Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]
Follow-up: DXA, mammogram, stool test and hepatitis C results at the six-month review. Zoster dose 2 in two to six months. Six-month review in two months, with Tdap, the influenza vaccine and zoster dose 2. Next scheduled visit 1877-09-14: six-month review: blood pressure at target, screening and bone density results, knee function, falls and social connection. [S]
Advance Care Planning
Voluntary advance care planning discussion of about 25 minutes, with her consent. She named a close friend of many years as her health care agent; the agent is recorded in the chart and not named here. Having nursed many people at the end of their lives, she said she knows what she would and would not want. She wants full treatment, including emergency stroke treatment, for any illness she could recover from. If a stroke or another illness left her unconscious or unable to know the people around her, with little hope of recovery, she would not want resuscitation, a breathing machine or tube feeding, and would want comfort care in her own rooms if possible, with her friends around her. She asked that her own remedies and massage be allowed for comfort if she wished. A written directive was completed and copied into the chart; it will be reviewed yearly. [S]